As of 2026-03-29, the Relative Valuation of Cresco Labs Inc (CL.CN) is (7.65) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.24 CAD, the upside of Cresco Labs Inc based on Relative Valuation is -717.3%.
The range of the Relative Valuation is (7.23) - (7.77) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.7x - 20.9x | 19.8x |
| Forward P/E multiples | 17.9x - 20.1x | 19.7x |
| Fair Price | (7.23) - (7.77) | (7.65) |
| Upside | -683.2% - -727.0% | -717.3% |
| Date | P/E |
| 2026-03-27 | -4.09 |
| 2026-03-26 | -4.45 |
| 2026-03-25 | -4.84 |
| 2026-03-24 | -4.80 |
| 2026-03-23 | -4.88 |
| 2026-03-20 | -4.59 |
| 2026-03-19 | -4.88 |
| 2026-03-18 | -4.73 |
| 2026-03-17 | -4.80 |
| 2026-03-16 | -4.66 |
| 2026-03-13 | -4.80 |
| 2026-03-12 | -4.66 |
| 2026-03-11 | -4.84 |
| 2026-03-10 | -4.55 |
| 2026-03-09 | -4.98 |
| 2026-03-06 | -4.95 |
| 2026-03-05 | -4.52 |
| 2026-03-04 | -4.77 |
| 2026-03-03 | -4.55 |
| 2026-03-02 | -4.48 |
| 2026-02-27 | -4.88 |
| 2026-02-26 | -4.91 |
| 2026-02-25 | -4.98 |
| 2026-02-24 | -5.05 |
| 2026-02-23 | -4.66 |
| 2026-02-20 | -4.70 |
| 2026-02-19 | -5.59 |
| 2026-02-18 | -4.91 |
| 2026-02-17 | -4.98 |
| 2026-02-13 | -4.95 |
| 2026-02-12 | -4.77 |
| 2026-02-11 | -4.88 |
| 2026-02-10 | -5.02 |
| 2026-02-09 | -5.31 |
| 2026-02-06 | -5.13 |
| 2026-02-05 | -4.95 |
| 2026-02-04 | -5.31 |
| 2026-02-03 | -5.16 |
| 2026-02-02 | -5.20 |
| 2026-01-30 | -5.09 |
| 2026-01-29 | -5.05 |
| 2026-01-28 | -5.27 |
| 2026-01-27 | -5.41 |
| 2026-01-26 | -5.81 |
| 2026-01-23 | -6.13 |
| 2026-01-22 | -6.13 |
| 2026-01-21 | -5.84 |
| 2026-01-20 | -5.91 |
| 2026-01-19 | -6.35 |
| 2026-01-16 | -6.42 |